Experiment 1123993

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationALAVI,JB: WEILER,CB: BRUNO,LA:. (1984). PHASE II EVALUATION OF VINDESINE IN THE TREATMENT OF MALIGNANT GLIOMA.. 68(5)
Amount utilized
Compound isolated
DiseaseA PHASE II STUDY. DOSE GIVEN WEEKLY FOR 16 WEEKS AFTER WHICH IT WAS GIVEN EVERY 2 WEEKS FOR TREATMENT OF MALIGNANT GLIOMA. 2 PATIENTS RESPONDED 1 WITH A REMISSION OF 1 1/2 YEARS,THE OTHER WITH A REMISSION OF 11 MONTHS. 5 PATIENTS HAD STABLE DISEASE FOR 3-28 MONTHS. TOXIC EFFECTS WERE MILD AND INCLUDED LEUKOPENIA,THROMBOCYTOPENIA,JAW PAIN,PARESTHESIA,CONSTIPATION AND A TRANSIENT ELEVATION IN TRANSAMINASE.
Dose amount3.0 MG
Number1
Qualitative result.
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE